日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Use of biologic drugs in juvenile idiopathic arthritis patients followed in an adult rheumatology clinic: real-life data from the HUR-BIO biologic registry

在成人风湿病诊所随访的幼年特发性关节炎患者中使用生物制剂:来自 HUR-BIO 生物制剂注册库的真实世界数据。

Ata, Emine Büşra; Kılıç, Levent; Fırlatan Yazgan, Büşra; Kart Bayram, Sevgi Gözde; Ekici, Mustafa; Ünaldı, Erdinç; Kuştaş, Ali Aytuğ; Bulat, Buğu; Karadağ, Ömer; Akdoğan, Ali; Apraş Bilgen, Şule; Kiraz, Sedat; Ertenli, İhsan; Bilginer, Yelda; Özen, Seza; Kalyoncu, Umut

ACPA is a main risk factor for CT-proven pulmonary nodule progression in patients with rheumatoid arthritis

ACPA是类风湿关节炎患者CT证实肺结节进展的主要危险因素

Uzun, Güllü Sandal; Sarıkaya, Yasin; Arslan, Sevtap; Ekici, Mustafa; Ata, Emine Büşra; Karcıoğlu, Oğuz; Bilgin, Emre; Kılıç, Levent; Kiraz, Sedat; Ertenli, Ali İhsan; Arıyürek, Macit; Kalyoncu, Umut

Real-World Insights From Türkiye: Biologic DMARDs Usage in Spondyloarthritis Patients With Chronic Kidney Disease

来自土耳其的真实世界见解:生物制剂DMARDs在合并慢性肾病的强直性脊柱炎患者中的应用

Bulut Gökten, Dilara; Tezcan, Mehmet Engin; Yağız, Burcu; Erden, Abdulsamet; Kimyon, Gezmiş; Yaşar Bilge, Nazife Şule; Kılıç, Levent; Coşkun, Belkıs Nihan; Ersözlü, Emine Duygu; Küçükşahin, Orhan; Koca, Süleyman Serdar; Gönüllü, Emel; Çınar, Muhammet; Akar, Servet; Emmungil, Hakan; Kaşifoğlu, Timuçin; Bes, Cemal; Ateş, Aşkın; Pehlivan, Yavuz; Kiraz, Sedat; Ertenli, Ali İhsan; Dalkılıç, Hüseyin Ediz; Kalyoncu, Umut; Mercan, Rıdvan

Predicting extra-musculoskeletal and peripheral manifestations and their role on biologic treatment in patients with axial spondyloarthritis: TReasure experience

预测中轴型脊柱关节炎患者的肌肉骨骼外和外周表现及其在生物治疗中的作用:TReasure 经验

Durak Ediboglu, Elif; Kalyoncu, Umut; Solmaz, Dilek; Yasar Bilge, Sule; Yılmaz, Sedat; Bes, Cemal; Erden, Abdulsamet; Yagız, Burcu; Özsoy, Zehra; Coskun, Belkıs Nihan; Mercan, Rıdvan; Kiraz, Sedat; Gönüllü, Emel; Yazısız, Veli; Alpay Kanıtez, Nilufer; Ateş, Askın; Yılmaz, Recep; Emmungil, Hakan; Kimyon, Gezmiş; Ersözlü, Emine Duygu; Koca, Süleyman Serdar; Ertenli, İhsan; Akar, Servet

Hematologic Malignancy Risk in Inflammatory Arthritis Patients Treated with TNF Inhibitors: The Real-Life Data from the HUR-BIO Registry

接受 TNF 抑制剂治疗的炎症性关节炎患者的血液系统恶性肿瘤风险:来自 HUR-BIO 注册研究的真实世界数据

Duran, Emine; Ozturk, Zeynep Ozge; Bilgin, Emre; Büyükaşık, Yahya; Dizdar, Omer; Yardimci, Gozde Kubra; Farisogullari, Bayram; Özsoy, Zehra; Ayan, Gizem; Uzun, Gullu Sandal; Ekici, Mustafa; Unaldi, Erdinc; Kilic, Levent; Akdoğan, Ali; Karadag, Omer; Bilgen, Şule Apraş; Kiraz, Sedat; Kalyoncu, Umut; Ertenli, Ali Ihsan

Epidemiological characteristics of hepatitis B and C in patients with inflammatory arthritis: Implications from treasure database

炎症性关节炎患者乙型和丙型肝炎的流行病学特征:来自TREAS数据库的启示

Ersözlü, Emine Duygu; Ekici, Mustafa; Coşkun, Belkis Nihan; Badak, Suade Özlem; Bilgin, Emre; Kalyoncu, Umut; Yağız, Burcu; Pehlivan, Yavuz; Küçükşahin, Orhan; Erden, Abdulsamet; Solmaz, Dilek; Atagündüz, Pamir; Kimyon, Gezmiş; Beş, Cemal; Çolak, Seda; Mercan, Rıdvan; Kaşifoğlu, Timuçin; Emmungil, Hakan; Alpay Kanıtez, Nilüfer; Ateş, Aşkın; Koca, Süleyman Serdar; Kiraz, Sedat; Ertenli, İhsan

Tocilizumab treatment in severe COVID-19: a multicenter retrospective study with matched controls

托珠单抗治疗重症 COVID-19:一项多中心回顾性研究及匹配对照

Mert, Ali; Vahaboğlu, Haluk; Arslan, Ferhat; Batirel, Ayşe; Saraçoğlu, Kemal Tolga; Bastug, Aliye; Çağatay, Atahan; Irmak, İlim; Dizman, Gülçin Telli; Ertenli, İhsan; Altunal, Lütfiye Nilsun; Sengel, Buket Ertürk; Bayram, Mehmet; Omma, Ahmet; Amikishiyev, Shirkhan; Aypak, Adalet; Bes, Cemal; Bolukçu, Sibel; Içten, Sacit; Topeli, Arzu; Bektaş, Murat; Arslan, Birsen Yiğit; Öztürk, Sinan; Çomoğlu, Şenol; Aydin, Selda; Küçükşahin, Orhan; Içaçan, Ozan Cemal; Ince, Burak; Aghamuradov, Sarvan; Mutlu, Melek Yalçin; Şimşek, Funda; Emre, Salih; Ustun, Cemal; Ergen, Pinar; Aydin, Özlem; Koç, Meliha Meriç; Sevindik, Ömür Gökmen; Odabaşı, Zekaver; Korten, Volkan; Bodur, Hurrem; Güner, Rahmet; Ünal, Serhat; Kocak, Mehmet; Gül, Ahmet

The First Effect of COVID-19 Pandemic on Starting Biological Disease Modifying Anti-Rheumatic Drugs: Outcomes from the TReasure Real-Life Database

COVID-19 大流行对启动生物制剂类疾病修饰抗风湿药物治疗的首要影响:来自 TReasure 真实世界数据库的结果

Alpay Kanıtez, Nilüfer; Kiraz, Sedat; Dalkılıç, Ediz; Kimyon, Gezmiş; Mercan, Rıdvan; Karadağ, Ömer; Bes, Cemal; Kılıç, Levent; Akar, Servet; Ateş, Aşkın; Emmungil, Hakan; Ertenli, İhsan; Pehlivan, Yavuz; Coşkun, Belkıs Nihan; Yağız, Burcu; Ersözlü, Duygu; Gönüllü, Emel; Çınar, Muhammet; Kaşifoğlu, Timuçin; Koca, Süleyman Serdar; Karasu, Uğur; Küçükşahin, Orhan; Kalyoncu, Umut

Proposal of a new nomenclature for the underlying pathogenetic mechanism of severe Coronavirus Disease-19: "Inflammatory Thrombosis with Immune Endotheliitis-ITIE"

关于严重冠状病毒病-19潜在发病机制的新命名提案:“伴免疫内皮炎的炎症性血栓形成-ITIE”

Bilgin, Emre; Ertenli, Ali İhsan

How did the updated hemodynamic definitions affect the frequency of pulmonary hypertension in patients with systemic sclerosis?

更新后的血流动力学定义对系统性硬化症患者肺动脉高压的发生率有何影响?

Sarı, Alper; Şener, Yusuf Ziya; Armağan, Berkan; Kılıç, Levent; Kaya, Ergün Barış; Hekimsoy, Vedat; Karadağ, Ömer; Apras Bilgen, Şule; Kiraz, Sedat; Ertenli, Ihsan; Tokgozoğlu, Lale; Akdoğan, Ali